The PFO closure device market is driven by a shift to minimally invasive solutions and patient-centric care. Opportunities lie in transcatheter methods, bioresorbable materials, regional reimbursement ...
Exact Sciences (EXAS) stock surges as Abbott Laboratories (ABT) agrees to acquire the company in a $21B all-cash acquisition.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback